Literature DB >> 6984188

B-cell growth factor: distinction from T-cell growth factor and B-cell maturation factor.

T Leanderson, E Lundgren, E Ruuth, H Borg, H Persson, A Coutinho.   

Abstract

A T-cell hybridoma was derived by somatic cell hybridization between concanavalin A-activated BALB/c spleen cells and the AKR thymoma BW 5147. Media conditioned by hybridoma cells, even at high dilutions (1:1,000) support the growth of lipopolysaccharide-stimulated B-cell blasts but not that of T-cell growth factor (TCGF)-reactive T-cells. This activity, herein designated B-cell growth factor (BCGF), has a Mr of approximately equal to 20,000 and it can readily be separated from TCGF (Mr approximately equal to 30,000) by gel filtration. BCGF is constitutively produced by the hybridoma cells, it is removed from conditioned media by incubation with target cells at +4 degrees C, and it is equally effective on B-cell blasts carrying different major histocompatibility complex and Ig haplotypes. BCGF shows no T-cell replacing factor (TRF) activity, and it is poor in supporting the development of Ig-secreting plaque-forming cells in B-cell blast cultures. Terminal maturation, however, can be induced in BCGF-dependent blasts by addition of conditioned media from normal helper T cell cultures, suggesting that two distinct factors are involved in the helper cell-dependent growth and maturation of B lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6984188      PMCID: PMC347358          DOI: 10.1073/pnas.79.23.7455

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  21 in total

1.  Studies on T lymphocyte activation II. The target cells for concanavalin A-induced growth factors.

Authors:  A Coutinho; E L Larsson; K O Grönvik; J Andersson
Journal:  Eur J Immunol       Date:  1979-08       Impact factor: 5.532

2.  Long term culture of tumour-specific cytotoxic T cells.

Authors:  S Gillis; K A Smith
Journal:  Nature       Date:  1977-07-14       Impact factor: 49.962

3.  Selective in vitro growth of T lymphocytes from normal human bone marrows.

Authors:  D A Morgan; F W Ruscetti; R Gallo
Journal:  Science       Date:  1976-09-10       Impact factor: 47.728

4.  The specificity of nonspecific concanavalin A-induced helper factors.

Authors:  R R Bernabe; C Martinez-Alonso; A Coutinho
Journal:  Eur J Immunol       Date:  1979-07       Impact factor: 5.532

5.  Replacement of T-cell function by a T-cell product.

Authors:  A Schimpl; E Wecker
Journal:  Nat New Biol       Date:  1972-05-03

6.  A plaque assay for all cells secreting Ig of a given type or class.

Authors:  E Gronowicz; A Coutinho; F Melchers
Journal:  Eur J Immunol       Date:  1976-08       Impact factor: 5.532

7.  Derivation of hybrids between a thymoma line and spleen cells activated in a mixed leukocyte reaction.

Authors:  G Köhler; I Lefkovits; B Elliott; A Coutinho
Journal:  Eur J Immunol       Date:  1977-11       Impact factor: 5.532

8.  Mitogen-activated B-cell blasts reactive to more than one mitogen.

Authors:  J Andersson; A Coutinho; F Melchers
Journal:  J Exp Med       Date:  1979-03-01       Impact factor: 14.307

9.  Restricted helper function of F1 hybrid T cells positively selected to heterologous erythrocytes in irradiated parental strain mice. II. Evidence for restrictions affecting helper cell induction and T-B collaboration, both mapping to the K-end of the H-2 complex.

Authors:  J Sprent
Journal:  J Exp Med       Date:  1978-04-01       Impact factor: 14.307

10.  Autoradiographic studies on the proliferation of antibody-producing cells in vitro.

Authors:  T Hünig; A Schimpl; E Wecker
Journal:  J Exp Med       Date:  1974-03-01       Impact factor: 14.307

View more
  12 in total

1.  Absence of three secreted proteins and presence of a 57-kDa protein related to irreversible arrest of cell growth.

Authors:  G Ching; E Wang
Journal:  Proc Natl Acad Sci U S A       Date:  1988-01       Impact factor: 11.205

2.  B cell growth factor activity in supernatants of MRL-lpr/lpr derived T cell hybridomas.

Authors:  U Schauer
Journal:  Clin Exp Immunol       Date:  1988-05       Impact factor: 4.330

3.  Polyclonal stimulation of resting B lymphocytes by antigen-specific T lymphocytes.

Authors:  A L DeFranco; J D Ashwell; R H Schwartz; W E Paul
Journal:  J Exp Med       Date:  1984-03-01       Impact factor: 14.307

4.  Antigen-specific helper T-cell clone supernatant is sufficient to induce both polyclonal proliferation and differentiation of small resting B lymphocytes.

Authors:  L Leclercq; G Bismuth; J Thèze
Journal:  Proc Natl Acad Sci U S A       Date:  1984-10       Impact factor: 11.205

5.  Development of a human T-cell hybridoma secreting separate B-cell growth and differentiation factors.

Authors:  J L Butler; R J Falkoff; A S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

6.  Interleukin-2 effects on human B cells activated in vivo.

Authors:  T Miyawaki; T Suzuki; J L Butler; M D Cooper
Journal:  J Clin Immunol       Date:  1987-07       Impact factor: 8.317

7.  Interleukin 2 induces antigen-reactive T cell lines to secrete BCGF-I.

Authors:  M Howard; L Matis; T R Malek; E Shevach; W Kell; D Cohen; K Nakanishi; W E Paul
Journal:  J Exp Med       Date:  1983-12-01       Impact factor: 14.307

8.  Human milk stimulates B cell function.

Authors:  P Juto
Journal:  Arch Dis Child       Date:  1985-07       Impact factor: 3.791

9.  Human interleukin 2 can promote the growth and differentiation of single hapten-specific B cells in the presence of specific antigen.

Authors:  B L Pike; A Raubitschek; G J Nossal
Journal:  Proc Natl Acad Sci U S A       Date:  1984-12       Impact factor: 11.205

10.  Evidence for two distinct classes of murine B cell growth factors with activities in different functional assays.

Authors:  S L Swain; M Howard; J Kappler; P Marrack; J Watson; R Booth; G D Wetzel; R W Dutton
Journal:  J Exp Med       Date:  1983-09-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.